(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

Inc., a pharmaceutical company specializing in preparations, has entered into a significant agreement that has led to the ...

Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock reserves for incentive plans, according to a filing with the Securities ...

Eyenovia, Inc. announced on January 15, 2025, that leading proxy advisory firms ISS and Glass Lewis have advised stockholders to vote in favor of a proposed reverse stock split at a ratio between ...

Virtual meeting scheduled for 10:00 a.m. ET on January 21st; stockholders must pre-register by 11:59 p.m. ET on January 20thNEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ ...

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

Eyenovia, Smart Share Hit Auction Block TD Bank is considering a Charles Schwab stake sale while Disney inks deal with FuboTV. Meanwhile, bankruptcy cases spiked in 2024.

Eyenovia has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.98, meaning that its stock price is 2% less ...

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its ...